ClinicalTrials.gg
Sign In

Lymphatic Metastasis clinical trials

The registry lists 213 studies for Lymphatic Metastasis across more than 10 countries. 77 are recruiting or about to start. 48 of them are mainly about Lymphatic Metastasis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

Get an email when these change. Save the Lymphatic Metastasis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
69
Status unknown
49
Recruiting
48
Not yet recruiting
23
Active, not recruiting
10
Enrolling by invitation
6

Phase

Phase 2
14
Phase 3
13
Phase 1
6
Phase 4
2

Where

China
76
Netherlands
20
Italy
17
United States
16
Denmark
8
Sweden
8

Who runs them

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (8) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (6) · Fudan University (6) · Radboud University Medical Center (6) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (4) · Maastricht University Medical Center (4) · IRCCS San Raffaele (3) · Odense University Hospital (3)

What is being tested here

Drugs under test in Lymphatic Metastasis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cisplatin313
Indocyanine Green113
Propranolol101
Tislelizumab101
Gemcitabine101
Iparomlimab101
Tuvonralimab101
Paclitaxel111
Cabozantinib011
QL2107011

Drug classes tested here Immune checkpoint inhibitors 2 open · Tyrosine kinase inhibitors (TKIs) 3

Coming up

5phase 3 studies under way
20studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 48 Lymphatic Metastasis studies recruiting now, 26 (54%) set no upper age limit and 8 (17%) stop at 75 or younger. 5 (10%) take children under 18. 13 (27%) are for women only and 2 (4%) for men only; 2 (4%) take healthy volunteers.

Recruiting studies that take each age, of 48
AgeWomenMen
105 (10%)5 (10%)
1842 (88%)32 (67%)
3045 (94%)35 (73%)
4045 (94%)35 (73%)
5046 (96%)35 (73%)
6546 (96%)35 (73%)
7544 (92%)34 (71%)
8533 (69%)26 (54%)

Across all 213 studies, recruiting or not: 17% stop at 75 or younger and 2% at 65; 15% take children; 20% are for women only and 8% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Lymphatic Metastasis studies take

Of 50 interventional studies with no phase under Lymphatic Metastasis, half reached primary completion within 64 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase64 mo35–98 · 50 studies——
Observational40 mo24–79 · 42 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Stopped1

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 213. Browse all 213 → or search them.